Many cancer medications fail to effectively target the most commonly mutated cancer genes in humans, called RAS. Now, scientists have uncovered details into how normal RAS interacts with mutated RAS and other proteins in living cells for the first time. The findings could aid in the development of better RAS-targeted cancer therapeutics.
from Top Health News -- ScienceDaily https://ift.tt/2ZjTOt1
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
India is the largest market by users for both Facebook and its messenger service WhatsApp from Home Page https://ift.tt/3aUtevW via IFTTT...
-
The Finance Industry Development Council (FIDC) has urged the Ministry of Micro, Small & Medium Enterprises (MSME) to address issues fac...
-
India has started exporting cereals like rice and wheat to new destinations, including Puerto Rico, Yemen and Poland, with a view to push ag...
No comments:
Post a Comment